| 2017 | | Identification of phenotypic clusters of nonsteroidal anti-inflammatory drugs exacerbated respiratory disease | 김승현, 박해심, 반가영, 신유섭, 예영민 |
| 2015 | | MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation. | 박해심 |
| 2017 | | Metabolomic analysis identifies potential diagnostic biomarkers for aspirin-exacerbated respiratory disease | 김승현, 박해심, 반가영, 신유섭, 예영민 |
| 2024 | | New targets for type 2-low asthma | 박해심 |
| 2023 | | Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper | 박해심 |
| 2017 | | Potential Biomarkers for NSAID-Exacerbated Respiratory Disease | 박해심, 정창규 |
| 2016 | | Predictors of asthma control in elderly patients | 박해심, 반가영, 예영민 |
| 2021 | | Recent update on the management of anaphylaxis | 박해심, 장재혁 |
| 2021 | | S100A9 in adult asthmatic patients: a biomarker for neutrophilic asthma | 박해심, 신유섭, 최영우 |
| 2022 | | Serum Amyloid A1: A Biomarker for Neutrophilic Airway Inflammation in Adult Asthmatic Patients | 박해심, 신유섭, 최영우 |
| 2016 | | Serum Clusterin as a Prognostic Marker of Chronic Spontaneous Urticaria | 박해심, 반가영, 신유섭, 예영민 |
| 2018 | | Serum Periostin Levels: A Potential Serologic Marker for Toluene Diisocyanate-Induced Occupational Asthma | 박해심, 신유섭, 예영민 |
| 2020 | | Serum potential biomarkers according to sputum inflammatory cell profiles in adult asthmatics | 박해심, 예영민 |
| 2021 | | Serum-free immunoglobulin E: A useful biomarker of atopy and type 2 asthma in adults with asthma | 박해심, 신유섭, 예영민, 이영수, 장재혁 |
| 2021 | | Sputum antinuclear antibody serves as a biomarker for severe asthma | 박해심, 신유섭 |
| 2019 | | The synergistic effects of clopidogrel with montelukast may be beneficial for asthma treatment | 박해심, 신유섭 |
| 2020 | | Toward personalization of asthma treatment according to trigger factors | 박해심 |
| 2015 | | Upper airways in aspirin-exacerbated respiratory disease. | 김지혜, 박해심 |
